Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2014-01-30 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Issue of Equity - Replacement
Share Issue/Capital Change Classification · 1% confidence The document is an amendment to a previous announcement released via RNS (RNS Number : 9301Y). The content explicitly details the 'Issue of Equity' (issuance of 11,428,571 ordinary shares) and corrects a price error from the original filing. This type of announcement regarding the issuance of new shares or changes in the total number of shares in issue directly corresponds to the 'Share Issue/Capital Change' definition. Therefore, the filing type code is SHA. The document is short and is a direct announcement, not a report itself, but SHA is more specific than RPA or RNS.
2014-01-30 English
Issue of Equity
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement, identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS'. The core content announces the 'Issue of Equity' (issuance of 11,428,571 ordinary shares) and the subsequent increase in the total number of shares in issue. This action directly relates to changes in the company's capital structure, specifically the issuance of new shares. This aligns precisely with the definition for 'Share Issue/Capital Change' (Code: SHA). Although it is an RNS announcement, the specific nature of the announcement (share issuance) makes SHA a more precise classification than the general fallback RNS.
2014-01-30 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Result of AGM' and confirms that 'all resolutions put to shareholders at the Annual General Meeting held today were duly approved.' This directly relates to the outcome of the Annual General Meeting. The most specific code for AGM-related outcomes is AGM-R (AGM Information), although DVA (Declaration of Voting Results & Voting Rights Announcements) is also highly relevant. Given the context is the announcement of the results immediately following the meeting, AGM-R is the primary fit for general AGM materials/results announcements, while DVA is strictly for the formal declaration of votes. Since this is a brief announcement confirming approval, AGM-R is appropriate. The document is very short (661 chars) and is an RNS announcement, but the content is specifically about the AGM result, making AGM-R the best fit over the general RNS fallback.
2013-12-17 English
Virtual Tumour Proposal
Regulatory Filings Classification · 1% confidence The document is very short (3047 characters) and announces a 'New Agreement to advance inhibitor of novel target with global pharma company'. It contains an RNS Number (6814U) and is dated 04 December 2013. This structure strongly suggests a regulatory news service announcement, which is typically brief and reports on a specific corporate event (like a new contract). Since the content is a specific corporate announcement that doesn't fit the definitions for M&A (TAR), Capital Change (CAP/SHA), Director Dealing (DIRS), or Dividend (DIV), and it is not a full report (like 10-K or IR), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly sourced from 'RNS The company news service from the London Stock Exchange'.
2013-12-04 English
DrugCARD launch
Environmental & Social Information Classification · 1% confidence The document starts with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content announces the launch of a new product, 'DrugCARD® database', by Physiomics plc. This is a general business update or announcement that does not fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Since it is a formal announcement disseminated via the RNS system (The company news service from the London Stock Exchange) and doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings fallback category (RNS). The document length (3428 chars) is short, but it is announcing a product launch, not the publication of a major report, so RPA is less suitable than RNS for this type of operational news.
2013-11-28 English
Final Results
Annual Report Classification · 1% confidence The document is titled 'Final Results for the year ended 30 June 2013' and contains detailed financial statements, including an Income Statement and a Statement of Financial Position, along with a Chairman's and CEO's statement. It is a comprehensive annual financial report for the company Physiomics PLC. While it is distributed via an RNS (Regulatory News Service) header, the content itself constitutes the full annual financial results, which qualifies as an Annual Report (10-K equivalent for UK-listed companies). FY 2013
2013-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.